Bladder Flap Technique In Elective Cesarean Section

Cesarean Delivery Clinical Trial

Official title:

Bladder Flap Versus Non Bladder Flap Technique In Women Undergoing Elective Cesarean Section A Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03016273
• Other study ID #: BFCS
• Status: Recruiting
• Phase: N/A
• First received: January 9, 2017
• Last updated: July 3, 2017
• Start date: February 20, 2017
• Est. completion date: March 2018

Study information

• Verified date: July 2017
• Source: Assiut University
• Contact: Yasmin Youssef, MBBCh
• Phone: 00201068248305
• Email: yasminalaa92[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cesarean section is a surgical procedure used to deliver one or more babies. cesarean section is usually performed when vaginal delivery will put the mother or child's health or life at risk. In recent years, the number of cesarean section has risen worldwide.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: March 2018
• Est. primary completion date: February 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

1. Patients undergoing elective primary cesarean section

2. previous cesarean section

3. gestational age 32 or more.

Exclusion Criteria:

1. Patients undergoing emergent cesarean section

2. Patients undergoing planned vertical uterine incision.

3. Patients undergone previous laparotomies.

4. Gestational age less than 32 weeks .

5. Patient refusing to participate in the study

6. Women with body mass index >35

Related Conditions & MeSH terms

• Cesarean Delivery

Intervention

Procedure:
• creation of bladder flap
Creation of the bladder flap, i.e., dissecting the urinary bladder from the lower segment of the uterus is a standard part of cesarean section (CS).

Locations

Country	Name	City	State
Egypt	Assuit university	Asyut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the skin - delivery time		duration of surgery